Scholarlink

Objectives <p>Uterine artery embolization (UAE) has emerged as a minimally invasive and uterus-preserving treatment option for symptomatic uterine fibroids. However, comprehensive short-term data integrating anatomical and functional outcomes remain limited. This study aimed to evaluate the effects of UAE on fibroid volume, menstrual pain, and female sexual function at 6-month follow-up.</p> Methods <p>Twenty-nine premenopausal women with symptomatic fibroids who underwent UAE and completed 6&#xa0;months of follow-up were included. Fibroid volume (measured via pelvic magnetic resonance imaging, MRI), dysmenorrhea severity (via Visual Analog Scale, VAS), and sexual function (assessed by the Female Sexual Function Index, FSFI) were evaluated before the procedure and at the 6-month follow-up. Postembolization complications were also recorded.</p> Results <p>The mean fibroid volume significantly decreased from 162.4 ± 122.6 cm<sup>3</sup> to 82.7 ± 83.9 cm<sup>3</sup>, corresponding to a 49.1% reduction (<i>p</i> &lt; 0.001). VAS scores for menstrual pain decreased by 27.6% (from 5.86 to 4.24; <i>p</i> = 0.027), and FSFI scores improved by 37.9% (from 22.07 to 30.44; <i>p </i>&lt; 0.001). No major complications were observed; minor side effects such as postembolization syndrome were managed conservatively.</p> Conclusions <p>UAE&#xa0;was associated with&#xa0;a significant reduction in fibroid volume and improvements in pain and sexual function&#xa0;at 6 months<b>.</b>&#xa0;Given the small sample size and short follow-up, these findings should be interpreted as short-term evidence from a pilot cohort, and larger, long-term prospective studies are needed to confirm durability and broader clinical effectiveness.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Safety and efficacy of uterine artery embolization for uterine fibroids: a prospective evaluation of volume reduction, menstrual pain, and sexual function

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月16日

查看全文
  • Özkan Alataş,
  • Eda Güner Özen,
  • Ahmet Ergin Çapar,
  • Mehmet Ferdi Kıncı,
  • Ahkam Göksel Kanmaz,
  • Yaşam Kemal Akpak,
  • Ümit Belet

摘要

Objectives

Uterine artery embolization (UAE) has emerged as a minimally invasive and uterus-preserving treatment option for symptomatic uterine fibroids. However, comprehensive short-term data integrating anatomical and functional outcomes remain limited. This study aimed to evaluate the effects of UAE on fibroid volume, menstrual pain, and female sexual function at 6-month follow-up.

Methods

Twenty-nine premenopausal women with symptomatic fibroids who underwent UAE and completed 6 months of follow-up were included. Fibroid volume (measured via pelvic magnetic resonance imaging, MRI), dysmenorrhea severity (via Visual Analog Scale, VAS), and sexual function (assessed by the Female Sexual Function Index, FSFI) were evaluated before the procedure and at the 6-month follow-up. Postembolization complications were also recorded.

Results

The mean fibroid volume significantly decreased from 162.4 ± 122.6 cm3 to 82.7 ± 83.9 cm3, corresponding to a 49.1% reduction (p < 0.001). VAS scores for menstrual pain decreased by 27.6% (from 5.86 to 4.24; p = 0.027), and FSFI scores improved by 37.9% (from 22.07 to 30.44; p < 0.001). No major complications were observed; minor side effects such as postembolization syndrome were managed conservatively.

Conclusions

UAE was associated with a significant reduction in fibroid volume and improvements in pain and sexual function at 6 months. Given the small sample size and short follow-up, these findings should be interpreted as short-term evidence from a pilot cohort, and larger, long-term prospective studies are needed to confirm durability and broader clinical effectiveness.